Latest by Sony Salzman

Project ECHO 'Telementoring' HIV Program Launches at Mount Sinai

On Jan. 4, clinicians across New York State booted up their computers and logged into a virtual classroom, each ready to learn how to improve care for their HIV patients.

By Sony Salzman

Now That We Have a Cure for Hepatitis C, What Are the Next Treatment Challenges?

Within the next few years, several pipeline hepatitis C drugs are expected to be approved in the U.S., ensuring that even the most difficult-to-treat patients can be cured -- but what challenges remain?

By Sony Salzman

Closing the Gap for Tough-to-Treat Hepatitis C Patients

Despite the diversity of new direct-acting antivirals (DAAs), a tiny number of patients are still left behind. Nancy Reau, M.D., presented a summary of soon-to-be-approved drugs that should work for these tough-to-treat patients.

By Sony Salzman

State Medicaid Programs Ease Illegal Restrictions on Hepatitis C Medications, but More Progress Needed

While restrictions for obtaining hepatitis C drugs through Medicaid programs vary state by state, restrictions eased somewhat across the country from 2014 to 2016, according to data presented at the Liver Meeting 2016.

By Sony Salzman

Spurred by Success of Remote Hepatitis C Care, Program Targets Remote Primary Care

A health program called Project ECHO successfully used telecommunication technology to coach local care providers on how to treat hepatitis C in New Mexico. Now its founder wants to expand the program to the rest of the world and all primary care....

By Sony Salzman

It's Time to Start Thinking About Anal Sex as a Risk Factor for HIV In Women

A staggering 38% of new HIV infections among low-income women in the U.S. may be due to anal intercourse, which is poorly understood in women, according to a study presented at HIVR4P 2016.

By Sony Salzman

What Are the Hepatitis C Genotypes?

Like other viruses, hepatitis C has evolved into distinct subgroups, which has made the virus difficult to treat with a universal drug. Here is a review of the main genotypes, where they are found and how to treat them.

By Sony Salzman

Should HIV Cure Research, Inspired by Advances in Fighting Cancer, Aim for Remission Not Eradication?

While a true cure remains elusive for both diseases, HIV researchers are looking at new advances in immuno-oncology for clues on how to achieve durable HIV remission.

By Sony Salzman

The Current State of HIV Cure Research: An Interview With Carl Dieffenbach

In this interview, Carl Dieffenbach, Ph.D., director of the Division of AIDS, National Institute of Allergy and Infection Diseases (NIAID), shares his thoughts on the challenges and opportunities ahead on the road toward an HIV cure.

By Sony Salzman

The Ethics of HIV Cure Trials

When it comes to clinical trials for HIV cures, many patient volunteers may be asked to stop taking their once-daily medicines to measure the true effect of the experimental treatment, raising ethical questions and concerns.

By Sony Salzman